These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38785056)

  • 1. [Application of HS221GI in treatment of influenza and ARVI in adults: a new approach - managing virus-induced inflammation. Results of a double-blind, randomized, placebo-controlled, multicenter clinical trial].
    Malyavin AG; Bagaeva MI; Kalyuzhin OV
    Ter Arkh; 2023 Dec; 95(12):1165-1171. PubMed ID: 38785056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the efficacy and safety of a complex antiviral drug based on antibodies in the treatment of adult patients with acute respiratory viral infection].
    Khamitov RF; Nikiforov VV; Zaytsev AA; Tragira IN
    Ter Arkh; 2022 Jan; 94(1):83-93. PubMed ID: 36286922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR).
    Pshenichnaya NY; Bulgakova VA; Lvov NI; Poromov AA; Selkova EP; Grekova AI; Shestakova IV; Maleev VV; Leneva IA
    Ter Arkh; 2019 Mar; 91(3):56-63. PubMed ID: 31094461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New opportunities for preventive anti-inflammatory therapy in the management of patients with moderate and severe COVID-19].
    Gorelov AV; Kalyuzhin OV; Bagaeva MI
    Ter Arkh; 2022 Aug; 94(7):872-875. PubMed ID: 36286945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial].
    Geppe NA; Kondiurina EG; Galustian AN; Pak TE; Bal'tserovich NB; Zhiglinskaia OV; Kamaev AV; Lazareva SG; Laléko SL; Mel'nikova IM; Perminova OA; Sabitov AU
    Antibiot Khimioter; 2014; 59(5-6):6-14. PubMed ID: 25552038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment for acute respiratory viral infection and influenza in daily clinical practice: Results of the multicenter international observational FLU-EE study].
    Fazylov VK; Sitnikov IG; Silina EV; Shevchenko SB; Mozhina LN; Zamyatina LL; Yeganyan GA; Groppa LG; Korsantia BM
    Ter Arkh; 2016; 88(11):68-75. PubMed ID: 28005034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR].
    Kiselev OI; Maleev VV; Deeva EG; Leneva IA; Selkova EP; Osipova EA; Obukhov AA; Nadorov SA; Kulikova EV
    Ter Arkh; 2015; 87(1):88-96. PubMed ID: 25823275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
    Yang Z; Li Z; Zhan Y; Lin Z; Fang Z; Xu X; Lin L; Li H; Lin Z; Kang C; Liang J; Liang S; Li Y; Li S; Yang X; Ye F; Zhong N;
    Lancet Infect Dis; 2024 May; 24(5):535-545. PubMed ID: 38330975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial].
    Kalyuzhin OV; Gorelov AV; Malyavin AG; Zaytsev AA; Esaulenko EV; Novak KE; Bykov AS
    Ter Arkh; 2023 Nov; 95(10):850-858. PubMed ID: 38159017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effectiveness of ARVI treatment regimen including etiotropic (enisamium iodide) and symptomatic treatment].
    Lioznov DA; Karnaukhova EJ; Zubkova TG; Shakhlanskaya EV
    Ter Arkh; 2020 Apr; 92(3):50-55. PubMed ID: 32598793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms.
    Grebe W; Ionescu E; Gold MS; Liu JM; Frank WO
    Clin Ther; 2003 Feb; 25(2):444-58. PubMed ID: 12749506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study.
    Beran J; Šalapová E; Špajdel M;
    BMC Infect Dis; 2016 Nov; 16(1):648. PubMed ID: 27821093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
    Ison MG; Portsmouth S; Yoshida Y; Shishido T; Mitchener M; Tsuchiya K; Uehara T; Hayden FG
    Lancet Infect Dis; 2020 Oct; 20(10):1204-1214. PubMed ID: 32526195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peculiarities of the influenza and ARVI viruses circulation during epidemic season 2019-2020 in some regions of Russia].
    L'vov DK; Burtseva EI; Kolobukhina LV; Fedyakina IT; Bovin NV; Ignatjeva AV; Krasnoslobodtsev KG; Feodoritova EL; Trushakova SV; Breslav NV; Merkulova LN; Mukasheva EA; Khlopova IN; Voronina OL; Aksyonova EI; Kunda MS; Ryzhova NN; Vartanjan RV; Kistenyova LB; Kirillov IM; Proshina ES; Rosatkevich AG; Kruzhkova IS; Zaplatnikov AL; Bazarova MV; Smetanina SV; Kharlamov MV; Karpov NL; Shikhin AV
    Vopr Virusol; 2021 Jan; 65(6):335-349. PubMed ID: 33533230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial.
    Haffizulla J; Hartman A; Hoppers M; Resnick H; Samudrala S; Ginocchio C; Bardin M; Rossignol JF;
    Lancet Infect Dis; 2014 Jul; 14(7):609-18. PubMed ID: 24852376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.
    Kumar D; Ison MG; Mira JP; Welte T; Hwan Ha J; Hui DS; Zhong N; Saito T; Katugampola L; Collinson N; Williams S; Wildum S; Ackrill A; Clinch B; Lee N
    Lancet Infect Dis; 2022 May; 22(5):718-730. PubMed ID: 35085510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.